221 related articles for article (PubMed ID: 9675327)
41. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
42. The role of natural biopolymers in genotoxicity of mutagens/carcinogens elimination.
Miadoková E; Svidová S; Vlcková V; Dúhová V; Prazmáriová E; Tothová K; Nad'ová S; Kogan G; Rauko P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):493-6. PubMed ID: 16601818
[TBL] [Abstract][Full Text] [Related]
43. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
Mauthe RJ; Gibson DP; Bunch RT; Custer L
Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
[TBL] [Abstract][Full Text] [Related]
44. The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo.
Verhagen H; Aruoma OI; van Delft JH; Dragsted LO; Ferguson LR; Knasmüller S; Pool-Zobel BL; Poulsen HE; Williamson G; Yannai S
Food Chem Toxicol; 2003 May; 41(5):603-10. PubMed ID: 12659712
[TBL] [Abstract][Full Text] [Related]
45. Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review.
Nehlig A; Debry G
Mutat Res; 1994 Apr; 317(2):145-62. PubMed ID: 7511793
[TBL] [Abstract][Full Text] [Related]
46. Time-dependent mutagenesis and cancer: a new role for antimutagenesis in cancer prevention?
MacPhee DG
Mutat Res; 1998 Jun; 402(1-2):29-39. PubMed ID: 9675238
[TBL] [Abstract][Full Text] [Related]
47. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
48. In vivo antimutagenic activity of beta-carotene in rat spleen lymphocytes.
Aidoo A; Lyn-Cook LE; Lensing S; Bishop ME; Wamer W
Carcinogenesis; 1995 Sep; 16(9):2237-41. PubMed ID: 7554082
[TBL] [Abstract][Full Text] [Related]
49. Anticarcinogenic activities of carotenoids in animals and cellular systems.
Krinsky NI
EXS; 1992; 62():227-34. PubMed ID: 1450588
[TBL] [Abstract][Full Text] [Related]
50. Mutagens that are not carcinogens: faulty theory or faulty tests?
Zeiger E
Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
[TBL] [Abstract][Full Text] [Related]
51. Beta-carotene: a cancer chemopreventive agent or a co-carcinogen?
Paolini M; Abdel-Rahman SZ; Sapone A; Pedulli GF; Perocco P; Cantelli-Forti G; Legator MS
Mutat Res; 2003 Jun; 543(3):195-200. PubMed ID: 12787812
[TBL] [Abstract][Full Text] [Related]
52. Introduction: utilization of higher plant systems as monitors of environmental mutagens.
de Serres FJ
Environ Health Perspect; 1978 Dec; 27():3-6. PubMed ID: 738246
[TBL] [Abstract][Full Text] [Related]
53. Increased attachment of nucleic acids to eukaryotic and prokaryotic cells induced by chemical and physical carcinogens and mutagens.
Kubinski H; Morin NR; Zeldin PE
Cancer Res; 1976 Sep; 36(9 pt.1):3025-33. PubMed ID: 975072
[TBL] [Abstract][Full Text] [Related]
54. The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.
Ntuli SSBN; Gelderblom WCA; Katerere DR
BMC Complement Altern Med; 2018 Mar; 18(1):93. PubMed ID: 29544492
[TBL] [Abstract][Full Text] [Related]
55. Natural antimutagenic agents.
Mitscher LA; Telikepalli H; McGhee E; Shankel DM
Mutat Res; 1996 Feb; 350(1):143-52. PubMed ID: 8657175
[TBL] [Abstract][Full Text] [Related]
56. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
57. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
Zeiger E
Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
[TBL] [Abstract][Full Text] [Related]
58. Antimutagenicity profiles for some model compounds.
Waters MD; Brady AL; Stack HF; Brockman HE
Mutat Res; 1990 Jan; 238(1):57-85. PubMed ID: 2406585
[TBL] [Abstract][Full Text] [Related]
59. Identification of 'genotoxic' and 'non-genotoxic' alerts for cancer in mice: the carcinogenic potency database.
Cunningham AR; Rosenkranz HS; Zhang YP; Klopman G
Mutat Res; 1998 Feb; 398(1-2):1-17. PubMed ID: 9626960
[TBL] [Abstract][Full Text] [Related]
60. Multiple antimutagenesis mechanisms affect mutagenic activity and specificity of the base analog 6-N-hydroxylaminopurine in bacteria and yeast.
Kozmin SG; Schaaper RM; Shcherbakova PV; Kulikov VN; Noskov VN; Guetsova ML; Alenin VV; Rogozin IB; Makarova KS; Pavlov YI
Mutat Res; 1998 Jun; 402(1-2):41-50. PubMed ID: 9675240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
